VIKING GLOBAL INVESTORS LP 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 0 0.000% | -19,283,744 (Position Closed) | Filing |
| 2021-02-12 8:00 pm Unchanged | 2020-12-31 | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 0 (Unchanged) | Filing |
| 2020-12-23 8:37 pm Unchanged | 2020-12-14 | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 0 (Unchanged) | Filing |
| 2020-12-21 5:28 pm Purchase | 2020-12-14 | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 19,283,744 (New Position) | Filing |